RemeGen Co., Ltd. reported earnings results for the half year ended June 30, 2023. For the half year, the company reported sales was CNY 419.07 million compared to CNY 348.78 million a year ago. Revenue was CNY 422.43 million compared to CNY 350.37 million a year ago.

Net loss was CNY 703.36 million compared to CNY 489.13 million a year ago. Basic loss per share from continuing operations was CNY 1.3 compared to CNY 0.96 a year ago. Diluted loss per share from continuing operations was CNY 1.3 compared to CNY 0.96 a year ago.